PHASE 1B RANDOMIZED CONTROLLED STUDY OF SHORT COURSE TOPICAL RECOMBINANT HUMAN NERVE GROWTH FACTOR (RHNGF) FOR NEUROENHANCEMENT IN GLAUCOMA: SAFETY, TOLERABILITY, AND EFFICACY MEASURE OUTCOMES (vol 234, pg 223, 2022)
AMERICAN JOURNAL OF OPHTHALMOLOGY（2022）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined